Cyclin-dependent kinase (CDK4/6), as well as its target protein, cyclin D1, is involved in cell cycle regulation and has been implicated in the pathogenesis of BC and the potential development of endocrine resistance [8]. This evidence concerns the gene CDK4 and breast cancer.